Contribution of polymeric materials to progress in xenotransplantation of microencapsulated cells - A review

Cell microencapsulation and subsequent transplantation of the microencapsulated cells require multidisciplinary approaches. Physical, chemical, biological, engineering, and medical expertise has to be combined. Several natural and synthetic polymeric materials and different technologies have been reported for the preparation of hydrogels, which are suitable to protect cells by microencapsulation. However, owing to the frequent lack of adequate characterization of the hydrogels and their components as well as incomplete description of the technology, many results of in vitro and in vivo studies appear contradictory or cannot reliably be reproduced. This review addresses the state of the art in cell microencapsulation with special focus on microencapsulated cells intended for xenotransplantation cell therapies. The choice of materials, the design and fabrication of the microspheres, as well as the conditions to be met during the cell microencapsulation process, are summarized and discussed prior to presenting research results of in vitro and in vivo studies. Overall, this review will serve to sensitize medically educated specialists for materials and technological aspects of cell microencapsulation.

Tailored Capsule Based Self-Healing for Epoxy Matrix Composites

Sam Neuser

Self-healing materials are a novel class of materials able to repair structural or, more generally, functional damage to a part. They hence have the potential to improve reliability and cost effectiveness, because failure or loss of functionality may be postponed or completely avoided. This concept has been applied to all classes of materials, but is particularly suited to polymers and their composites. Indeed, it was first demonstrated for epoxies containing capsules of dicyclopentadiene and dispersed Grubbs’ catalyst. However, the high cost of the catalyst precludes commercial use of this self-healing system. In the present thesis, two alternative approaches to self-healing of an epoxy matrix were investigated: (1) a solvent based self-healing epoxy; (2) a two-component epoxy/amine self-healing system using a novel encapsulation technique. The solvent-based system showed efficient healing in an under-cured epoxy matrix. The solvent in question was ethyl phenylacetate (EPA) encapsulated with urea-formaldehyde (UF) or UF-polyurethane. It was demonstrated that during a crack event, the solvent diffused into the epoxy matrix following a non-Fickian case II profile, with a geometrical swelling of the surface layer of the crack. For a healing time of 24h, a critical crack gap of 30μm was identified, beyond which the swelling was insufficient to bridge the crack faces and the healing efficiency was limited to around 25%. For smaller crack gaps, solvent swelling led to intimate contact of the crack faces and reaction of residual functional groups through a reduction of the glass transition temperature Tg of the epoxy, resulting in improved healing efficiency. The use of shape memory alloys (SMA) that are strained during the fracture event and subsequently heated to reduce the crack opening was also investigated. High healing efficiencies were observed and it was found that longer SMA wire activation times further improved the healing efficiency up to almost 80% through improved crack closure and an increased degree of polymerization. The behavior of this material during aging was then investigated in partially cracked samples, guaranteeing small crack gaps. It was found that the premature diffusion of the solvent through the microcapsule membrane into the epoxy matrix led to a decrease in healing efficiency from around 75% in fresh samples, to about 15% in samples aged for 75 days. Increasing the thickness of the polymeric shell of the capsules did not significantly improve performance. Moreover, moisture uptake by the epoxy also contributed to the reduced healing efficiency. Because the healing agent is hydrophobic, a higher water content in the epoxy matrix limited solvent diffusion into the epoxy and hence the extent of healing. A potential solution to the problem of premature diffusion of solvent into the epoxy is suggested to be the use of other shell materials or additional coatings on the capsules. The response of the solvent based self-healing system to dynamic fatigue was also studied. While in static testing, matrix swelling governs crack healing, a different mechanism was observed in the case of dynamic loading. In contrast to the unmodified epoxy, which showed rapid crack propagation under all the conditions investigated, in the presence of the solvent, crack arrest was observed for stress intensities of up to 0.48 MPam1/2. This phenomenon was attributed to crack pinning owing to diffusion of the solvent into the matrix surrounding the crack tip. The elongation at break of the solvated epoxy increased threefold, and the Young’s modulus decreased by more than 50%. Using finite element analysis (FEM) to model the stress distribution around the solvent-infused crack tip, it was shown that the local crack tip stress was reduced by 43%, accounting for this novel toughening effect. While solvent healing performed well in an under-cured matrix and interesting phenomena were observed, a fully cured matrix with a two-component self-healing system may be preferable for real applications because it avoids issues pertaining to premature solvent diffusion. The possibility of encapsulating an amine curing agent in a core-shell structure was therefore investigated as an alternative. A microfluidic glass chip was used to encapsulate a hydrophilic amine/water based curing agent in an acrylate resin shell using ex-situ exposure to UV light. Low viscosity epoxy was encapsulated with UF using a modified agitated emulsion encapsulation technique. Successful self-healing was demonstrated for epoxy specimens containing these microcapsules, along with embedded SMA wires, with healing efficiencies of up to 100% and 40% for low and high temperature curing epoxy, respectively. Overall, this work represents a significant step towards affordable epoxy self-healing materials, the feasibility of solvent and epoxy/amine healing having been successfully demonstrated for an epoxy matrix. The epoxy/amine self-healing system is thought to be particularly promising, considering the early stage of development. Furthermore, the integration of SMA wires proved to improve healing efficiencies dramatically, especially with the epoxy/amine microcapsules. With further optimization and scale-up of the microfluidic encapsulation method, a new low cost self-healing system, and hence potentially compatible with a wide range of polymeric materials, including composites, is therefore within reach because it is based on a commonly used epoxy/amine adhesive.

EPFL2013

Alginate-Poly(ethylene glycol) Hybrid Microspheres for Primary Cell Microencapsulation

Redouan Mahou, Christine Wandrey

The progress of medical therapies, which rely on the transplantation of microencapsulated living cells, depends on the quality of the encapsulating material. Such material has to be biocompatible, and the microencapsulation process must be simple and not harm the cells. Alginate-poly(ethylene glycol) hybrid microspheres (alg-PEG-M) were produced by combining ionotropic gelation of sodium alginate (Na-alg) using calcium ions with covalent crosslinking of vinyl sulfone-terminated multi-arm poly(ethylene glycol) (PEG-VS). In a one-step microsphere formation process, fast ionotropic gelation yields spherical calcium alginate gel beads, which serve as a matrix for simultaneously but slowly occurring covalent cross-linking of the PEG-VS molecules. The feasibility of cell microencapsulation was studied using primary human foreskin fibroblasts (EDX cells) as a model. The use of cell culture media as polymer solvent, gelation bath, and storage medium did not negatively affect the alg-PEG-M properties. Microencapsulated EDX cells maintained their viability and proliferated. This study demonstrates the feasibility of primary cell microencapsulation within the novel microsphere type alg-PEG-M, serves as reference for future therapy development, and confirms the suitability of EDX cells as control model.

Mdpi Ag2014

Development of functionalized alginate-based hydrogels to reduce fibrosis in the transplantation of microencapsulated cells

François Rémi Pierre Noverraz

Nowadays, the development of cell therapy relies mainly on the advances made toward cell microencapsulation which allows to evade the need for immunosuppression during cell transplantation. Among the materials considered for cell encapsulation, hydrogels distinguish themselves by their exceptional properties. Due to its gelling properties in contact with divalent cations, the biopolymer sodium alginate (Na-alg), has been widely studied for the microencapsulation and transplantation of cells. However, several defects notably in permselectivity and durability in vivo is limiting the translation of alginate-based hydrogels in clinical applications. In addition, the transplantation of cells without immunosuppressive treatment have to face adverse host responses such as inflammation and fibrosis. At the moment, several approaches have been considered for the development of an ideal material for cell encapsulation; however many challenges still remain in this domain. Hence, this research project focused on the development of hydrogels in order to improve their properties toward cell encapsulation. The first part of this research focused on the development of new types of one-component hybrid alginate-based hydrogels. These hydrogels combine the gelling properties of Na-alg with covalent crosslinking within the same polymeric structure. In order to do so, a new synthetic approach was developed allowing the functionalization on the hydroxyl position of alginate with heterobifunctional poly(ethylene glycol) (PEG) linkers through carbamate bond. This allowed to maintain the carboxyl moieties available for the formation of electrostatic interactions. Two types of one-component hybrid hydrogel were developed with this method adding either thiols or lipoyl moieties on alginate leading to an improvement of mechanical properties while preserving a good biocompatibility. Yet, transplantation of encapsulated cells in a foreign host body have to face immune response, in particular inflammation and pericapsular fibrosis overgrowth (PFO) which ultimately leads to necrosis of the encapsulated cells and loss of graft functionality. Therefore, the second part of this research project focused on tuning the composition of the polymeric components of the hydrogels with anti-inflammatory agents which would reduce PFO in vivo. Different anti-inflammatory agents were considered for this purpose. The best candidate (ketoprofen) was then PEGylated via either ester or amide bond and grafted on the backbone of alginate to ensure a controlled release at the site of transplantation. By analyzing the fibrotic tissue around the microspheres, it was observed that the incorporation of ketopreofen on the structure of the hydrogel significantly reduced PFO 30 days after transplantation. In summary, Na-alg was functionalized with a new synthetic methodology allowing the incorporation of either functionalities reinforcing the mechanical resistance of the hydrogel or anti-inflammatory compounds improving the biocompatibility of the graft.